Equities

AlzeCure Pharma AB

AlzeCure Pharma AB

Actions
  • Price (SEK)1.05
  • Today's Change0.045 / 4.48%
  • Shares traded119.24k
  • 1 Year change-71.53%
  • Beta0.5245
Data delayed at least 15 minutes, as of Nov 22 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

AlzeCure Pharma AB (ALZCUR:STO) set a new 52-week low during Thursday's trading session when it reached 0.94. Over this period, the share price is down -71.01%.
52-week range
Today
0.94Nov 21 20243.77Mar 01 2024
Open1.02
High1.05
Low0.946
Bid1.02
Offer1.05
Previous close1.01
Average volume162.10k
Shares outstanding88.30m
Free float51.28m
P/E (TTM)--
Market cap88.74m SEK
EPS (TTM)-0.5055
SEK
Data delayed at least 15 minutes, as of Nov 22 2024 17:00 GMT.
More ▼

Events & Activity

  • ALZCUR:STO price reached a new 52-week low of 1.11 at 05:42 GMT
  • ALZCUR:STO trading volume exceeds daily average by +173.76%
  • ALZCUR:STO price reached a new 52-week low of 1.11 at 03:51 GMT
  • ALZCUR:STO price moved over +10.28% to 1.40
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.